CME Group Future Growth
Future criteria checks 1/6
CME Group is forecast to grow earnings and revenue by 3.1% and 3.4% per annum respectively. EPS is expected to grow by 2.9% per annum. Return on equity is forecast to be 13.7% in 3 years.
Key information
3.1%
Earnings growth rate
2.9%
EPS growth rate
| Capital Markets earnings growth | 13.8% |
| Revenue growth rate | 3.4% |
| Future return on equity | 13.7% |
| Analyst coverage | Good |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Trade On, Cash In: Why CME Group Is My Pick For Income And Growth
Oct 27Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?
Oct 23
CME Group: An Attractive Business Relatively Out Of Favor
Oct 15CME Group: An Interesting Option For Every Dividend Investor
Oct 08CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate
Sep 03CME Group Has It All - Growth, Dividend Growth, And Value
Aug 26Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks
Aug 01CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings
Jul 02CME Group: FMX Market Entry Poses Real Risk
Jul 01CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Jun 05Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance
May 25CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
May 21Gunning For CME's Golden Goose
May 01Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results
Apr 26CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty
Apr 15CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates
Mar 27CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15
Mar 05CME Group Is One Of My Favorite High-Yielding Stocks Today
Feb 29CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15
Feb 20CME Group: Buying 'The House' Proves A Winning Strategy
Feb 14CME Group: Uncertainty In The World Equals Higher Revenue Growth
Feb 04Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely
Dec 27Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors
Nov 14We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation
Apr 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6,551 | 3,688 | 3,975 | 4,215 | 12 |
| 12/31/2025 | 6,263 | 3,524 | 3,827 | 4,005 | 15 |
| 12/31/2024 | 6,112 | 3,442 | 3,756 | 3,940 | 15 |
| 9/30/2024 | 6,034 | 3,422 | 3,628 | 3,717 | N/A |
| 6/30/2024 | 5,788 | 3,262 | 3,492 | 3,571 | N/A |
| 3/31/2024 | 5,616 | 3,157 | 3,363 | 3,444 | N/A |
| 12/31/2023 | 5,569 | 3,186 | 3,377 | 3,454 | N/A |
| 9/30/2023 | 5,338 | 3,011 | 3,311 | 3,391 | N/A |
| 6/30/2023 | 5,228 | 2,942 | 3,108 | 3,192 | N/A |
| 3/31/2023 | 5,104 | 2,828 | 3,078 | 3,159 | N/A |
| 12/31/2022 | 5,009 | 2,657 | 2,966 | 3,056 | N/A |
| 9/30/2022 | 4,833 | 2,633 | 2,650 | 2,743 | N/A |
| 6/30/2022 | 4,715 | 2,889 | 2,616 | 2,717 | N/A |
| 3/31/2022 | 4,657 | 2,745 | 2,477 | 2,599 | N/A |
| 12/31/2021 | 4,690 | 2,617 | 2,275 | 2,402 | N/A |
| 9/30/2021 | 4,630 | 2,435 | 2,225 | 2,394 | N/A |
| 6/30/2021 | 4,600 | 1,920 | 1,888 | 2,074 | N/A |
| 3/31/2021 | 4,603 | 1,913 | 2,378 | 2,561 | N/A |
| 12/31/2020 | 4,884 | 2,105 | 2,518 | 2,716 | N/A |
| 9/30/2020 | 4,911 | 2,151 | 2,581 | 2,775 | N/A |
| 6/30/2020 | 5,109 | 2,375 | 3,071 | 3,274 | N/A |
| 3/31/2020 | 5,200 | 2,386 | 2,521 | 2,761 | N/A |
| 12/31/2019 | 4,868 | 2,117 | 2,427 | 2,673 | N/A |
| 9/30/2019 | 4,959 | 2,033 | 2,229 | 2,464 | N/A |
| 6/30/2019 | 4,588 | 1,808 | 2,027 | 2,236 | N/A |
| 3/31/2019 | 4,377 | 1,860 | 2,137 | 2,285 | N/A |
| 12/31/2018 | 4,309 | 1,962 | 2,324 | 2,441 | N/A |
| 9/30/2018 | 3,973 | 4,516 | 2,301 | 2,391 | N/A |
| 6/30/2018 | 3,959 | 4,413 | N/A | 2,316 | N/A |
| 3/31/2018 | 3,824 | 4,262 | N/A | 2,057 | N/A |
| 12/31/2017 | 3,645 | 4,063 | N/A | 1,751 | N/A |
| 9/30/2017 | 3,658 | 1,498 | N/A | 1,801 | N/A |
| 6/30/2017 | 3,609 | 1,662 | N/A | 1,773 | N/A |
| 3/31/2017 | 3,590 | 1,566 | N/A | 1,732 | N/A |
| 12/31/2016 | 3,595 | 1,534 | N/A | 1,732 | N/A |
| 9/30/2016 | 3,496 | 1,452 | N/A | 1,607 | N/A |
| 6/30/2016 | 3,505 | 1,340 | N/A | 1,591 | N/A |
| 3/31/2016 | 3,418 | 1,284 | N/A | 1,626 | N/A |
| 12/31/2015 | 3,327 | 1,247 | N/A | 1,533 | N/A |
| 9/30/2015 | 3,354 | 1,262 | N/A | 1,644 | N/A |
| 6/30/2015 | 3,266 | 1,192 | N/A | 1,414 | N/A |
| 3/31/2015 | 3,178 | 1,191 | N/A | 1,327 | N/A |
| 12/31/2014 | 3,113 | 1,127 | N/A | 1,291 | N/A |
| 9/30/2014 | 2,958 | 1,014 | N/A | 1,171 | N/A |
| 6/30/2014 | 2,911 | 960 | N/A | 1,066 | N/A |
| 3/31/2014 | 2,990 | 1,008 | N/A | 1,268 | N/A |
| 12/31/2013 | 2,931 | 977 | N/A | 1,281 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CME's forecast earnings growth (3.1% per year) is above the savings rate (2.6%).
Earnings vs Market: CME's earnings (3.1% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: CME's earnings are forecast to grow, but not significantly.
Revenue vs Market: CME's revenue (3.4% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: CME's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CME's Return on Equity is forecast to be low in 3 years time (13.7%).